Cell Therapy Technologies Market Revenue, Growth, Current Trends, Future Growth Study and Strategic Assessment
Cell Therapy Technologies Market Revenue, Growth, Current Trends, Future Growth Study and Strategic Assessment
Market growth is driven mainly by increasing research in regenerative medicine along with stem cell research, cancer research, and cell biology research

Cell Therapy Technologies Market is projected to grow from USD 4.0 billion in 2022 to USD 8.0 billion by 2027, at a CAGR of 14.6% from 2022 to 2027, according to a new report by MarketsandMarkets™. Growth in the market can be attributed to number of cell therapy clinical trials related to cancer. Furthermore, increasing incidence of communicable diseases and the growing risk of pandemics are also expected to fuel the market growth.

Cell therapy technologies are medical treatments that involve the use of living cells or their derivatives to treat or prevent disease. These therapies are being used to treat a wide range of diseases and conditions, including cancer, autoimmune diseases, and heart disease.

The global cell therapy technologies market is expected to grow at a significant rate during the forecast period owing to the increasing prevalence of chronic and degenerative diseases, technological advancements, and rising government funding for cell therapy research. The increasing number of clinical trials and the increasing focus on personalized medicine are expected to drive the market growth.

However, the high cost associated with cell therapy and the lack of infrastructure for cell therapy research are expected to hamper the growth of the market. The growing adoption of cell therapy technologies in emerging economies and the increasing focus on regenerative medicine are expected to present opportunities for the growth of the market.

Get a sample of the report:

Top Lading Players: Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Becton, Dickinson and Company (US), Fresenius SE & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte Inc. (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), TrakCel (UK), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), GPI Iberia (Spain), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Manufacturing Corporation (US)

Some Key Highlights from the Report:

1. The global cell therapy technologies market is projected to reach USD 8.0 billion by 2027 from USD 4.0 billion in 2022, at a CAGR of 14.6%.

2. The cell therapy technologies market is driven by the rising incidence of chronic diseases, increasing investments in stem cell research, and technological advancements in stem cell isolation and culture.

3. On the basis of product, the cell therapy technologies market is segmented into cell isolation/enrichment systems, cell culture systems, cell banks, cell delivery systems, and analytical instruments.

4. Based on application, the market is segmented into cancer, autoimmune & inflammatory diseases, cardiovascular diseases, neurological diseases, and other applications.

5. The cell therapy technologies market is dominated by North America, followed by Europe.

6. The key players in the market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), Lonza Group AG (Switzerland), Terumo BCT, Inc. (US), STEMCELL Technologies, Inc.

Ask for Customize Research Report:

Segments covered in the report:

By Product

  • Media, Sera, and Reagents
  • Cell Engineering Products
  • Cell Culture Vessels
  • Cell Therapy Equipment
  • Cell Processing Equipment
  • Single-use Equipment
  • Other Equipment
  • Systems and Software
  • Other Products

By Process

  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control

By Cell Type

  • T-cells
  • Stem Cells
  • Other Cells

By End User

  • Biopharmaceutical and Biotechnology Companies
  • CROs and CMOs
  • Research Institutes and Cell Banks

Regional Outlook:

·         North America (U.S.A., Canada, Mexico)

·         Europe (Italy, U.K., Germany, France, Rest of Europe)

·         Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)

·         Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)

·         Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Questions Addressed in the Report:

1.       What are the dominating factors that are influencing the growth of the industry?

2.       In the forecast period, which market segment is expected to rise the most?

3.       What are the risks and challenges that the industry is facing?

4.       In the coming years, which area is projected to dominate the market?

5.       Who are the major players in the market?

6.       What kind of strategic business plans have they made?

Make and inquire to buy this Report @

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441